"Iyad is a dynamic leader with more than 20 years of experience in architecture and engineering design operations, business development and project management," said Pankaj Duggal, President – ...

Eve Burstein, an analyst from Bernstein, maintained the Buy rating on Thermo Fisher (TMO – Research Report). The associated price target was ...

The drug discovery services market is expanding, driven by advancements in biotechnology, personalized medicine, and the increasing demand for efficient, cost-effective drug development solutions.” - ...

Thermo Fisher returned to growth in 4Q 2024 with 6.6% projected EPS growth. Learn why TMO stock’s leadership position and ...

Contentious hearings to consider Robert F. Kennedy Jr. to lead the Department of Health and Human Services this week have ...

Goldman Sachs analyst Matthew Sykes raised the firm’s price target on Thermo Fisher (TMO) to $670 from $630 and keeps a Buy rating on the ...

Thursday closed up +0.53%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.38%, and the Nasdaq 100 Index ($IUXX) ...

Shares of Thermo Fisher Scientific jumped Thursday after the company's fourth-quarter results topped estimates, as sales increased across all four of its divisions.

The S&P 500 Index ($SPX) (SPY) today is up +0.24%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.33%, and the Nasdaq ...

Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.

Earlier this week, Franco-German peer Sartorius reported preliminary annual results that beat expectations and posted a 23.1% ...

PORTLAND, IA, UNITED STATES, January 30, 2025 /EINPresswire / -- Alarming rise in prevalence of cancer & infectious disease and increase in number of approval for exosome therapeutics & diagnostics ...